For highly polar drugs (e.g. mannitol) what primarily determines elimination rate?

Highly polar drugs, such as mannitol, aminoglycosides, and polar sugar alcohols, possess low lipophilicity and high water solubility. Because hepatic metabolism relies predominantly on lipophilic interactions with cytochrome P450 and phase II enzymes to transform nonpolar substances into hydrophilic derivatives, highly polar drugs bypass metabolic transformation almost entirely. Furthermore, these hydrophilic molecules cannot easily cross lipid cell membranes, preventing significant tissue distribution or intracellular metabolism. Consequently, their systemic elimination rate is almost completely governed by renal excretion mechanisms, primarily glomerular filtration. Therefore, the excretion rate serves as the primary rate-limiting step determining the overall elimination rate constant and systemic clearance of highly polar drug compounds in clinical practice.

B: Highly polar drugs undergo negligible hepatic metabolism because metabolic enzymes primarily target lipophilic molecules to facilitate their conversion into polar compounds for excretion. C: Absorption rate dictates the rate at which drug enters systemic circulation, not the clearance or elimination process once the drug is already in systemic blood. D: Distribution rate describes drug movement between vascular and extravascular spaces, whereas elimination permanently removes active drug from the body via excretion or biotransformation. E: Only renal excretion rate primarily determines the overall elimination rate of highly polar drugs, making the inclusion of metabolism, absorption, and distribution incorrect.

- Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2017). Goodman & Gilman's: The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill Education. Chapter 2: Drug Excretion and Renal Clearance, pp. 21–38.

- Stanford University School of Medicine. Courseware on Principles of Clinical Pharmacology: Renal Elimination and Clearance Kinetics.